{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:29:45Z","timestamp":1790504985741,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1007\/s11882-002-0032-z","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T17:35:02Z","timestamp":1180805702000},"page":"9-15","source":"Crossref","is-referenced-by-count":22,"title":["T cells in drug allergy"],"prefix":"10.1007","volume":"2","author":[{"given":"Werner J.","family":"Pichler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"32_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1398-9995.1998.tb03881.x","volume":"53","author":"WJ Pichler","year":"1998","unstructured":"Pichler WJ, Schnyder B, Zanni M, et al.: Role of T cells in drug allergies Allergy 1998, 53:225\u2013232.","journal-title":"Allergy"},{"key":"32_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/jid.1995.19","volume":"105","author":"M Hertl","year":"1995","unstructured":"Hertl M, Merk HF: Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 1995, 105:95\u201398.","journal-title":"J Invest Dermatol"},{"key":"32_CR3","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1365-2222.2001.01164.x","volume":"31","author":"Y Hari","year":"2001","unstructured":"Hari Y, Frutig K, Hurni M, et al.: T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001, 31:1398\u20131408. The first study to evaluate, in a prospective way, the value of the lymphocyte transformation test in the diagnosis of drug allergy (sensitivity was found to be 68%). It shows clear differences in the clinical picture of drug allergies dependent on the extent of CD8 cell activation.","journal-title":"Clin Exp Allergy"},{"key":"32_CR4","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.4049\/jimmunol.155.5.2670","volume":"55","author":"C Brander","year":"1995","unstructured":"Brander C, Mauri-Hellweg D, Bettens F, et al.: Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 1995, 55:2670\u20132678.","journal-title":"J Immunol"},{"key":"32_CR5","doi-asserted-by":"crossref","unstructured":"Britschgi M, Steiner U, Schmid S, et al.: T cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001, in press. Delineates the pathomechanism of acute generalized exanthematous pustulosis and describes a new T cell subset secreting high IL-8 levels.","DOI":"10.1172\/JCI12118"},{"key":"32_CR6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.158.3.1139","volume":"158","author":"MP Zanni","year":"1997","unstructured":"Zanni MP, Mauri-Hellweg D, Brander C, et al.: Characterization of lidocaine-specific T cells. J Immunol 1997, 158:1139\u20131148.","journal-title":"J Immunol"},{"key":"32_CR7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","volume":"100","author":"B Schnyder","year":"1997","unstructured":"Schnyder B, Mauri-Hellweg D, Zanni M, et al.: Direct, MHCdependent presentation of the drug sulfamethoxazole to human T cell clones. J Clin Invest 1997, 100:136\u2013141.","journal-title":"J Clin Invest"},{"key":"32_CR8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI3544","volume":"102","author":"MP Zanni","year":"1998","unstructured":"Zanni MP, von Greyerz S, Schnyder B, et al.: HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human ab T lymphocytes. J Clin Invest 1998, 102:1591\u20131598. This paper gives unequivocal evidence for a processing-independent recognition of the chemically inert parent compound by drug-specific T cell clones.","journal-title":"J Clin Invest"},{"key":"32_CR9","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.1365-2222.1998.00419.x","volume":"28","author":"B Schnyder","year":"1998","unstructured":"Schnyder B, Frutig K, Mauri-Hellweg D, et al.: T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazoleinduced skin reaction. Clin Exp Allergy 1998, 28:1412\u20131417. Defines the role of cytotoxic CD4+ T cells in MPE, their killing of activated keratinocytes, and the involvement of perforin and not FasL.","journal-title":"Clin Exp Allergy"},{"key":"32_CR10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2222.2000.00847.x","volume":"30","author":"N Yawalkar","year":"2000","unstructured":"Yawalkar N, Egli F, Hari Y, et al.: Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000, 30:847\u2013855. Ex vivo data confirming the concept elaborated in reference [8]: CD4+ T cells kill keratinocytes in MPE.","journal-title":"Clin Exp Allergy"},{"key":"32_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-483X(95)03253-C","volume":"107","author":"HU Weltzien","year":"1996","unstructured":"Weltzien HU, Moulin C, Martin S, et al.: T cell immune response to haptens: structural models for allergic and autoimmune reactions. Toxicology 1996, 107:141\u2013151.","journal-title":"Toxicology"},{"key":"32_CR12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1067\/mai.2000.109828","volume":"106","author":"SJ Posadas","year":"2000","unstructured":"Posadas SJ, Leyva L, Torres MJ, et al.: Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000, 106:769\u2013776.","journal-title":"J Allergy Clin Immunol"},{"key":"32_CR13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2133.1995.tb05016.x","volume":"132","author":"M Hertl","year":"1995","unstructured":"Hertl M, Jugert F, Merk HF: CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br J Dermatol 1995, 132:215\u2013220.","journal-title":"Br J Dermatol"},{"key":"32_CR14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0091-6749(99)70489-6","volume":"103","author":"RS Kalish","year":"1999","unstructured":"Kalish RS, Askenase PW: Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma and autoimmunity. J Allergy Clin Immunol 1999, 103:192\u2013199. A comprehensive review of the role of CD8+ T cells in drug\/chemicalinduced immune reactions.","journal-title":"J Allergy Clin Immunol"},{"key":"32_CR15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.61.5.643","volume":"61","author":"K Landsteiner","year":"1935","unstructured":"Landsteiner K, Jacobs J: Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1935, 61:643\u2013656.","journal-title":"J Exp Med"},{"key":"32_CR16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/tx980058f","volume":"11","author":"BK Park","year":"1998","unstructured":"Park BK, Pirmohamed M, Kitteringham NR: Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem Res Toxicol 1998, 11:969\u2013988. A profound review of the hapten and prohapten concept, with emphasis on the role of drug metabolism.","journal-title":"Chem Res Toxicol"},{"key":"32_CR17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/eji.1830270602","volume":"27","author":"E Padovan","year":"1997","unstructured":"Padovan E, Bauer T, Tongia MM, et al.: Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997, 27:1303\u20131307.","journal-title":"Eur J Immunol"},{"key":"32_CR18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-5699(98)80012-1","volume":"19","author":"P Griem","year":"1998","unstructured":"Griem P, Wulferink M, Sachs B, et al.: Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 1998, 19:133\u2013141.","journal-title":"Immunol Today"},{"key":"32_CR19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bjp.0704074","volume":"139","author":"DJ Naisbitt","year":"2001","unstructured":"Naisbitt DJ, Gordon SF, Pirmohamed M, et al.: Antigenicity and immunogenicity of sulfamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br J Pharmacol 2001, 139:295\u2013305. Illustrates the immunogenicity of sulfamethoxazole-nitroso (SMXNO) compared with SMX in a rat model. First experimental proof of the prohapten concept, as immunization with SMX in complete Freund\u2019s adjuvant leads to a T cell immune response to SMX-NO.","journal-title":"Br J Pharmacol"},{"key":"32_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/208057a0","volume":"208","author":"CH Schneider","year":"1965","unstructured":"Schneider CH, de Weck AL: A new chemical aspect of penicillin allergy: the direct reaction of penicillin with epsilonamino- groups. Nature 1965, 208:57\u201359.","journal-title":"Nature"},{"key":"32_CR21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/clpt.1992.57","volume":"51","author":"AE Cribb","year":"1992","unstructured":"Cribb AE, Spielberg SP: Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 1992, 51:522\u2013526.","journal-title":"Clin Pharmacol Ther"},{"key":"32_CR22","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1747.2000.00985.x","volume":"114","author":"TP Reilly","year":"2000","unstructured":"Reilly TP, Lash LH, Doll MA, et al.: A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide- induced cutaneous drug reactions. J Invest Dermatol 2000, 114:1164\u20131173. This paper provides evidence that SMX can be metabolized by keratinocytes. However, the quantities of metabolites generated are much lower than with liver cells.","journal-title":"J Invest Dermatol"},{"key":"32_CR23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4049\/jimmunol.162.1.595","volume":"162","author":"S Greyerz von","year":"1999","unstructured":"von Greyerz S, Zanni M, Frutig K, et al.: Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole specific ab+ T cell clones. J Immunol 1999, 162:595\u2013602. An elegant evaluation of the fine specificity of sulfonamide-specific T cell clones and a demonstration that drug-specific TCR recognizes drugs like peptides (sequential triggering model).","journal-title":"J Immunol"},{"key":"32_CR24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/intimm\/10.4.507","volume":"10","author":"MP Zanni","year":"1998","unstructured":"Zanni MP, von Greyerz S, Schnyder B, et al.: HLA-unrestricted presentation of lidocaine by HLA-DR molecules to specific ab+ T cell clones. Int Immunol 1998, 10:507\u2013515. Demonstration that different HLA molecules can present the drug (bound in a noncovalent way) to some drug-specific TCC. This implies that the HLA-DR allele is not a limiting factor in T cell-mediated drug allergy, as different alleles can present the drug bound in a noncovalent way.","journal-title":"Int Immunol"},{"key":"32_CR25","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","volume":"164","author":"B Schnyder","year":"2000","unstructured":"Schnyder B, Burkhart C, Schnyder-Frutig K, et al.: Recognition of sulfamethoxazole and its reactive metabolites by drug specific T cells from allergic individuals. J Immunol 2000, 164:6647\u20136654. Of 222 T cell clones generated from two SMX allergic individuals, only eight reacted with the SMX-NO metabolite. Thus, the primary immune response also is directed to SMX itself and not the chemically reactive metabolite.","journal-title":"J Immunol"},{"key":"32_CR26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjp.0703845","volume":"132","author":"C Burkhart","year":"2001","unstructured":"Burkhart C, von Greyerz S, Depta JP, et al.: Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells. Br J Pharmacol 2001, 132:623\u2013630. A study demonstrating that there is no effect of glutathione on SMX recognition, but there is enhanced recognition of SMX-NO (as it is transformed to SMX, which is better recognized).","journal-title":"Br J Pharmacol"},{"key":"32_CR27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000024192","volume":"119","author":"S Greyerz von","year":"1999","unstructured":"von Greyerz S, Burkhart C, Pichler WJ: Molecular basis of drug recognition by specific T cell receptors. Int Arch Allergy Immunol 1999, 119:173\u2013180. An elegant model illustrating the relationship between fine specificity of drug-specific TCR and HLA-allele restriction.","journal-title":"Int Arch Allergy Immunol"},{"key":"32_CR28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0952-7915(00)00191-6","volume":"13","author":"S Gallucci","year":"2001","unstructured":"Gallucci S, Matzinger P: Danger signals: SOS to the immune system. Curr Opin Immunol 2001, 13:114\u2013119.","journal-title":"Curr Opin Immunol"},{"key":"32_CR29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0738-081X(99)00144-3","volume":"18","author":"HM Heller","year":"2000","unstructured":"Heller HM: Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection. Clin Dermatol 2000, 18:485\u2013489.","journal-title":"Clin Dermatol"},{"key":"32_CR30","first-page":"1108","volume":"134","author":"Y Suzuki","year":"1996","unstructured":"Suzuki Y, Inage R, Aono T, et al.: Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermotol 1996, 134:1108\u20131112.","journal-title":"Arch Dermotol"},{"key":"32_CR31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/03009749950154220","volume":"28","author":"JA Antonen","year":"1999","unstructured":"Antonen JA, Markula KP, Pertovaara MI, Pasternack AI: Adverse drug reactions in Sj\u00f6gren syndrome. Frequent allergic reactions and a specific trimethoprim-associated systemic reaction. Scand J Rheumatol 1999, 28:157\u2013159.","journal-title":"Scand J Rheumatol"},{"key":"32_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0300-483X(00)00399-1","volume":"158","author":"WJ Pichler","year":"2001","unstructured":"Pichler WJ: Predictive drug allergy testing, an alternative viewpoint. Toxicology 2001, 158:31\u201341. Summarizes the implication of the concept of noncovalent drug presentation to predictive drug allergy testing. Not only chemical, but also structural factors have to be considered in predictive drug allergy testing.","journal-title":"Toxicology"},{"key":"32_CR33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1523-1747.ep12260501","volume":"55","author":"MJ Fellner","year":"1970","unstructured":"Fellner MJ, Prutkin L: Morbilliform eruptions caused by penicillin. A study by electron microscopy and immunologic tests. J Invest Dermatol 1970, 55:390\u2013395.","journal-title":"J Invest Dermatol"},{"key":"32_CR34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0733-8635(05)70106-6","volume":"17","author":"AN Crowson","year":"1999","unstructured":"Crowson AN, Magro CM: Recent advances in the pathology of cutaneous drug eruptions. Dermatol Clin 1999, 17:537\u2013560.","journal-title":"Dermatol Clin"},{"key":"32_CR35","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2000.110922","volume":"106","author":"N Yawalkar","year":"2000","unstructured":"Yawalkar N, Shrikhande M, Hari Y, et al.: Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 2000, 106:1171\u20131176.","journal-title":"J Allergy Clin Immunol"},{"key":"32_CR36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2249.1994.tb06078.x","volume":"97","author":"A Carr","year":"1994","unstructured":"Carr A, Vasak E, Munro V, et al.: Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection. Clin Exp Immunol 1994, 97:260\u2013265.","journal-title":"Clin Exp Immunol"},{"key":"32_CR37","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archderm.134.8.1040","volume":"134","author":"AM Barbaud","year":"1998","unstructured":"Barbaud AM, Bene MC, Reichert-Penetrat S, et al.: Immunocompetent cells and adhesion molecules in 14 cases of cutaneous drug reactions induced with the use of antibiotics. Arch Dermatol 1998, 134:1040\u20131041. A detailed immunohistochemical analysis of drug eruptions with special reference to the involvement of adhesion molecules.","journal-title":"Arch Dermatol"},{"key":"32_CR38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archderm.1997.03890400081011","volume":"133","author":"AM Barbaud","year":"1997","unstructured":"Barbaud AM, Bene MC, Schmutz JL, et al.: Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashes. Arch Dermatol 1997, 133:481\u2013486.","journal-title":"Arch Dermatol"},{"key":"32_CR39","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1034\/j.1398-9995.2000.00628.x","volume":"55","author":"M Blanca","year":"2000","unstructured":"Blanca M, Posadas S, Torres MJ, et al.: Expression of the skinhoming receptor in peripheral blood lymphocytes from subjects with non immediate cutaneous allergic drug reactions. Allergy 2000, 55:998\u20131004.","journal-title":"Allergy"},{"key":"32_CR40","first-page":"365","volume":"10","author":"C Behrendt","year":"2000","unstructured":"Behrendt C, Gollnick H, Bonnekoh B: Up-regulated perforin expression of CD8+ blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psoriasis. Eur J Dermatol 2000, 10:365\u2013369.","journal-title":"Eur J Dermatol"},{"key":"32_CR41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1523-1747.2000.00105.x","volume":"115","author":"N Yawalkar","year":"2000","unstructured":"Yawalkar N, Hari Y, Frutig K, et al.: T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J Invest Dermatol 2000, 115:647\u2013652. First illustration that about 30% of skin-infiltrating T cells in patch test reactions are drug specific; some have cytotoxic potential, others secrete cytokines (in particular, IL-5).","journal-title":"J Invest Dermatol"},{"key":"32_CR42","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, et al.: Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998, 282:490\u2013493. Elaboration of the role of FasL-Fas killing in generalized bullous skin reactions and proposal that immunoglobulin therapy is of benefit in the treatment of TEN (which, however, in a recent French study could not be confirmed).","journal-title":"Science"},{"key":"32_CR43","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4049\/jimmunol.163.2.1053","volume":"163","author":"F Brugnolo","year":"1999","unstructured":"Brugnolo F, Annunziato F, Sampognaro S, et al.: Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions. J Immunol 1999, 163:1053\u20131059.","journal-title":"J Immunol"},{"key":"32_CR44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000024271","volume":"120","author":"Y Hari","year":"1999","unstructured":"Hari Y, Urwyler A, Hurni M, et al.: Distinct serum cytokine levels in drug or measels induced exanthema. Int Arch Allergy Immunol 1999, 120:225\u2013229.","journal-title":"Int Arch Allergy Immunol"},{"key":"32_CR45","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1365-2133.1998.02559.x","volume":"139","author":"G Choquet-Kastylevsky","year":"1998","unstructured":"Choquet-Kastylevsky G, Intrator L, Chenal C, et al.: Increased levels of Interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol 1998, 139:1026\u20131032.","journal-title":"Br J Dermatol"},{"key":"32_CR46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2249.1994.tb06078.x","volume":"97","author":"A Carr","year":"1994","unstructured":"Carr A, Vasak E, Munro V, et al.: Immunohistological assessement of cutaneous drug hypersensitivity in patients with HIV infection. Clin Exp Immunol 1994, 97:260\u2013265.","journal-title":"Clin Exp Immunol"},{"key":"32_CR47","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0960-9822(06)00371-X","volume":"7","author":"BO Gerber","year":"1997","unstructured":"Gerber BO, Zanni MP, Uguccioni M, et al.: Functional expression of the eotaxin receptor, CCR3, in T lymphocytes co-localizing with eosinophils. Curr Biol 1997, 7:836\u2013843.","journal-title":"Curr Biol"},{"key":"32_CR48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","volume":"119","author":"Cleach L Le","year":"2000","unstructured":"Le Cleach L, Delaaire S, Boumsell L, et al.: Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol 2000, 119:225\u2013230. The first functional analysis of blister fluid lymphocytes of patients with TEN reveals a cytotoxic potential and a peculiar, natural killer-like phenotype in a high proportion of cells.","journal-title":"Clin Exp Immunol"},{"key":"32_CR49","first-page":"222","volume":"24","author":"A Nassif","year":"2001","unstructured":"Nassif A, Bensussan A, Doroth\u00e9e G, et al.: Drug-specific cytotoxic T lymphocytes in the skin lesions of a patient with toxic epidermal necrolysis. Allergologie 2001, 24:222.","journal-title":"Allergologie"},{"key":"32_CR50","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archderm.1991.01680080069004","volume":"127","author":"J Roujeau","year":"1991","unstructured":"Roujeau J, Bioulac-Sage P, Bourseau C: Acute generalized exanthematous pustulosis: Analysis of 63 cases. Arch Dermatol 1991, 127:1333\u20131338.","journal-title":"Arch Dermatol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-002-0032-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-002-0032-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-002-0032-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:25:51Z","timestamp":1683865551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-002-0032-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s11882-002-0032-z","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}